Alexander Zehnder
Amministratore Delegato presso CUREVAC N.V.
Provenienza dei contatti di primo grado di Alexander Zehnder
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
17
| Public Company | Pharmaceuticals: Major | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Alexander Zehnder tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| 2INVEST AG | Financial Conglomerates | Compliance Officer | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Public Communications Contact | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Executive Officer Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Public Communications Contact | |
20 Minuten-Holding AG
 20 Minuten-Holding AG Publishing: NewspapersConsumer Services Part of Schibsted ASA, 20 Minuten-Holding AG is a holding group with interests in publishing. The company is based in Zurich, Switzerland. The Swiss company was founded by Hans Christoph Tanner. Sverre Christian Munck has been the CEO of the company since 2002. | Publishing: Newspapers | Founder | |
Ernst Mueller Moehl
 Ernst Mueller Moehl Investment Banks/BrokersFinance Ernst Mueller Moehl provides investment services. The private company is based in Zurich, Switzerland. and has subsidiaries in Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal | |
| University of Utah | College/University | Doctorate Degree | |
| The University of Edinburgh | College/University | Graduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member | |
| London School of Economics & Political Science | College/University | Undergraduate Degree | |
| University of Mannheim | College/University | Undergraduate Degree | |
| Universität Saarbrücken | College/University | Graduate Degree | |
UBS South Africa (Pty) Ltd.
 UBS South Africa (Pty) Ltd. Investment Banks/BrokersFinance UBS South Africa (Pty) Ltd. (UBSSA) is the broker subsidiary of UBS AG, which is ultimately held by UBS Group AG (NYSE: UBS). The firm is headquartered in Johannesburg. UBSSA provides brokerage services to private, institutional and corporate clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
Lion Bioscience, Inc.
 Lion Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Lion Bioscience, Inc. provides integrated solutions for genomics and bioinformatics. The private company is based in Cambridge, MA. | Miscellaneous Commercial Services | General Counsel | |
| CASSIOPEA S.P.A. | Pharmaceuticals: Major | Director of Finance/CFO | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Director/Board Member | |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Otto-von-Guericke-Universität Magdeburg | College/University | Doctorate Degree | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
GEUDER AG
 GEUDER AG Medical SpecialtiesHealth Technology GEUDER AG manufactures ophthalmic surgical instruments and systems. Its products include eye specula, retractors, foreign body instruments, scissors, forceps, needle holders and sterilization containers and adapters. The company was founded by Hans Geuder, Sr. in 1951 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
UBS Australia Pty Ltd.
 UBS Australia Pty Ltd. Investment ManagersFinance Part of UBS Group AG, UBS Australia Pty Ltd. is an Australian company that provides wealth management, asset management and investment banking services. The company is based in Sydney, Australia. The CEO of the company is Matthew Grounds. | Investment Managers | Corporate Officer/Principal | |
| dievini Verwaltungs GmbH | Chief Executive Officer | ||
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member | |
| PIXIUM VISION | Medical Specialties | Director of Finance/CFO | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Director/Board Member | |
dievini patch Beteiligungs GmbH
 dievini patch Beteiligungs GmbH Financial ConglomeratesFinance dievini patch Beteiligungs GmbH provides investment services. The company is headquartered in Andernach, Germany. | Financial Conglomerates | Chief Executive Officer | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director of Finance/CFO | |
FARa Holz AG
 FARa Holz AG Forest ProductsNon-Energy Minerals FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees. | Forest Products | Director/Board Member | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
Curevac Aktiebolag
 Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Containers/Packaging | Chief Executive Officer | |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
 TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Real Estate Development | Chief Executive Officer | |
Wyss Zurich
 Wyss Zurich Investment ManagersFinance Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015. | Investment Managers | Director/Board Member | |
| African Research Excellence Fund | Director/Board Member | ||
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Hmm Consulting | Chief Executive Officer | ||
| IMMATICS N.V. | Biotechnology | Director/Board Member | |
Lifematrix Technologies AG
 Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Lifematrix Technologies AG develops human cell-derived and off-the-shelf available tissue-engineered implants. The company is based in Zurich, Switzerland. The Swiss company was founded by René Stenger and Robin Müller. The CEO is Maximilian Emmert. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Germania | 22 |
| Svizzera | 9 |
| Stati Uniti | 7 |
| Francia | 4 |
| Italia | 4 |
Settori
| Health Technology | 21 |
| Finance | 10 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 80 |
| Corporate Officer/Principal | 34 |
| Chairman | 33 |
| Chief Executive Officer | 18 |
| Independent Dir/Board Member | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Baron Jean Stéphenne | 36 |
| Hans Tanner | 24 |
| Craig Tooman | 22 |
| Mathias Hothum | 19 |
| Klaus Schollmeier | 17 |
| Michael Brosnan | 14 |
| Ralf Clemens | 14 |
| Debra Stephanie Barker | 11 |
| Franz-Werner Haas | 9 |
| Igor Splawski | 8 |
| Viola Bronsema | 7 |
| Pierre Kemula | 5 |
| Sarah Fakih | 5 |
| Antony Blanc | 5 |
| Malte Greune | 5 |
- Borsa valori
- Insiders
- Alexander Zehnder
- Connessioni Società
